(Q36441491)

14 August 2017

1 reference

title

New strategies to combat filariasis (English)

1 reference

14 August 2017

0 references

Achim Hoerauf

1

1 reference

14 August 2017

1 April 2006

1 reference

Expert Review of Anti-infective Therapy

14 August 2017

1 reference

14 August 2017

4

1 reference

14 August 2017

211-222

1 reference

14 August 2017

2

1 reference

Animated documentation of the filaria dance sign (FDS) in bancroftian filariasis

14 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Localized eosinophil degranulation mediates disease in tropical pulmonary eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

New insights into the natural history and pathology of bancroftian filariasis: implications for clinical management and filariasis control programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

T regulatory-1 cells induce IgG4 production by B cells: role of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Comparative evaluation of three new tools for diagnosis of bancroftian filariasis based on detection of specific circulating antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

A new tool to assess the adulticidal efficacy in vivo of antifilarial drugs for bancroftian filariasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Ivermectin as an antiparasitic agent for use in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Albendazole for the control and elimination of lymphatic filariasis: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Mass drug treatment for lymphatic filariasis and onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Final report of the Conference on the eradicability of Onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Disease eradication, elimination and control: the need for accurate and consistent usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Control of onchocerciasis today: status and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Impact of ivermectin on illness and disability associated with onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Drug resistance in veterinary helminths

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Identification of variant ABC-transporter genes among Onchocerca volvulus collected from ivermectin-treated and untreated patients in Ghana, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Current status and future prospects of the Global Lymphatic Filariasis Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Albendazole: a review of anthelmintic efficacy and safety in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a ho

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Major progress toward eliminating lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Mass treatment to eliminate filariasis in Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Wolbachia bacteria of filarial nematodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Obligatory symbiotic Wolbachia endobacteria are absent from Loa loa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Evidence against Wolbachia symbiosis in Loa loa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

The Wolbachia genome of Brugia malayi: endosymbiont evolution within a human pathogenic nematode

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

The annotated genome of Wolbachia from the filarial nematode Brugia malayi: what it means for progress in antifilarial medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

First sequenced genome of a parasitic nematode

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

Macrofilaricidal activity of tetracycline against the filarial nematode Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.2.211

21 January 2018

Identifiers

DOI

10.1586/14787210.4.2.211

1 reference

14 August 2017

1 reference

PubMed ID

16597203